€14.48
1.63%
Xetra, Dec 05, 05:35 pm CET
ISIN
DE000A1MMCC8
Symbol
ILM1
Index

Medios Stock price

€14.48
+2.24 18.30% 1M
+2.48 20.67% 6M
+1.26 9.53% YTD
+1.20 9.04% 1Y
-5.97 29.19% 3Y
-22.22 60.55% 5Y
+6.98 93.07% 10Y
+6.98 93.07% 20Y
Xetra, Closing price Fri, Dec 05 2025
-0.24 1.63%
ISIN
DE000A1MMCC8
Symbol
ILM1
Index

Key metrics

Basic
Market capitalization
€375.4m
Enterprise Value
€480.0m
Net debt
€104.6m
Cash
€93.4m
Shares outstanding
24.5m
Valuation (TTM | estimate)
P/E
16.3 | 13.7
P/S
0.2 | 0.2
EV/Sales
0.2 | 0.2
EV/FCF
5.3
P/B
0.7
Financial Health
Equity Ratio
54.6%
Return on Equity
2.5%
ROCE
6.2%
ROIC
4.5%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
€2.0b | €2.0b
EBITDA
€82.5m | €92.9m
EBIT
€44.6m | €50.9m
Net Income
€22.0m | €26.0m
Free Cash Flow
€91.3m
Growth (TTM | estimate)
Revenue
9.3% | 7.9%
EBITDA
50.1% | 47.6%
EBIT
59.3% | 60.8%
Net Income
71.0% | 106.9%
Free Cash Flow
212.4%
Margin (TTM | estimate)
Gross
9.7%
EBITDA
4.1% | 4.6%
EBIT
2.2%
Net
1.1% | 1.3%
Free Cash Flow
4.5%
More
EPS
€0.9
FCF per Share
€3.7
Short interest
-
Employees
712
Rev per Employee
€2.6m
Show more

Is Medios a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Medios Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Medios forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a Medios forecast:

Buy
92%
Hold
8%

Financial data from Medios

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,013 2,013
9% 9%
100%
- Direct Costs 1,818 1,818
6% 6%
90%
194 194
47% 47%
10%
- Selling and Administrative Expenses 68 68
47% 47%
3%
- Research and Development Expense - -
-
-
83 83
50% 50%
4%
- Depreciation and Amortization 38 38
41% 41%
2%
EBIT (Operating Income) EBIT 45 45
59% 59%
2%
Net Profit 22 22
71% 71%
1%

In millions EUR.

Don't miss a Thing! We will send you all news about Medios directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Provision of Medicinal Products, Patient-specific Therapies, and Services. The Provision of Medicinal Products segment focuses on specialty pharmaceuticals means it trades almost exclusively in expensive medicinal products for chronic and/or rare diseases. The Patient-specific Therapies segment include infusions constituted and produced on the basis of individual symptoms and individual parameters such as body weight and body surface. The Services segment consists of all other Group activities, including Medios Group holding activities. The company was founded in 1980 and is headquartered in Berlin, Germany.

Head office Germany
CEO Matthias Gärtner
Employees 712
Founded 1980
Website medios.group

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today